Thumbnail Image

Avian influenza vaccine producers and suppliers for poultry (June 2009)

Year of publication 2009

Pages 4

Author Animal Production and Health Division

Product type Book (stand-alone)

Edition 1

Synopsis (short abstract) N.B. This list is to provide information on vaccine manufacturers and suppliers. The manufacturers and their vaccines are not necessarily endorsed by FAO and it is the country’s responsibility that independent quality assurance/quality control for safety, purity, potency, and efficacy parameters be established.

Language English

Also available in:
No results found.

Related items

Showing items related by metadata.

  • Thumbnail Image
    Book (series)
    Rational use of vaccination for control and prevention of H5 highly pathogenic avian influenza (EMPRES FOCUS ON) 2016
    Also available in:
    Vaccination can play a valuable role in control, prevention and elimination of highly pathogenicity avian influenza (HPAI) viruses in poultry. However, risk of adverse consequences as well as concerns about availability of sufficient resources to conduct vaccination programmes often restrain countries from embarking on vaccination. This document discusses concerns regarding poultry vaccination for H5 HPAI, with the aim to facilitate decision making in affected countries or those at risk of H5 HP AI incursion. The document contributes to FAO’s Strategic Objective 5 by helping to increase the resilience of livelihoods to threats from HPAI.
  • Thumbnail Image
    Book (stand-alone)
    Avian influenza vaccination in Egypt: Limitations of the current strategy 2009
    Also available in:
    No results found.
    Vaccination of domestic poultry against avian influenza (AI) has been used on a large-scale in South East Asia since 2003 and in Egypt since 2006 to fight H5N1 highly-pathogenic avian influenza (HPAI) epidemics. The decision to use mass vaccination against HPAI in Egypt was taken as an emergency measure based on positive impact of such control measures in Vietnam and the People’s Republic of China. However, three years on, the impact on disease control of AI vaccination in Egypt has been very li mited. Despite the continuous vaccination of poultry against HPAI, poultry outbreaks and human cases are reported regularly...
  • Thumbnail Image
    Article
    Avian influenza vaccine supply chain in Quang Ninh province, Vietnam, 2021 2023
    Also available in:
    No results found.
    Highly pathogenic avian influenza (HPAI) is a zoonotic disease that can affect both poultry and humans. Since 2005, the Vietnam government has implemented a national vaccination campaign to prevent the spread of avian influenza (AI). In 2021, the first outbreak of HPAI H5N8 was reported in a chicken farm in Quang Ninh province. To gain a comprehensive understanding of the chain and its relevance to HPAI vaccination in various aspects, and to identify and comprehend the stakeholders involved in the AI campaign and their roles within the vaccine supply chain. A cross-sectional study was conducted from Nov-2021 to Jan- 2022. We purposively selected 114 participants, including 71 poultry farmers using HPAI vaccines, 16 veterinary drug store owners, 18 commune animal health workers (CAHWs), 8 staff from the Centers for Agricultural Services (ATSCs), and one vaccine distributor who were interviewed face-to-face using a structured questionnaire. Three HPAI vaccines (H5N1 clade 1 & 2.3.2.1, H5N1 clade 2.3.4, and H5N1 clade 2.3.2.1b) were used. Distributors stored vaccines at the required temperature and transported them in appropriate vehicles. Vaccines remained in the supply chain for 3–5 months within their 12-month shelf-life period. The free government vaccination campaign, implemented by CAHWs, and administered by the ATSCs, reached 61% of small-scale poultry farms with a 1.19% vaccine wastage rate. Large-scale poultry farms followed the national campaign but paid a fee for the vaccines. We recommend expanding the support for AI vaccination to increase the vaccination rate among large-scale poultry farms, selecting higher efficacy seed vaccines, and that smaller dose vaccine vials are available for cost-effective vaccination.
Show more

Users also downloaded

Showing related downloaded files

No results found.